Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Tom Murphy

UnitedHealth Group’s stock plummets after DOJ investigation report

UnitedHealth have denied any wrongdoing. - (Copyright 2024 The Associated Press. All rights reserved.)

UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into the health care giant's Medicare billing practices.

The Wall Street Journal said federal officials have launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over.

The paper, citing anonymous sources, said the probe focused on billing practices in recent months.

UnitedHealth said it wasn't aware of the start of any new activity as the paper reported. It criticized the Journal's report and said in a statement posted on its website, "Any suggestion that our practices are fraudulent is outrageous and false."

Flags fly at half-staff outside UnitedHeathcare’s headquarters after CEO Brian Thompson was fatally shot. (REUTERS)

The company's UnitedHealthcare business covers more than 7.8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts.

The Journal's report "adds to a growing worry that expanded oversight around the insurers, particularly in the MA program, could pressure business practices, earnings, and investor sentiment," Leerink Partners analyst Whit Mayo said in a research note.

Shares of the Minnetonka, Minnesota, company fell more than 6% Friday. Shares of other prominent Medicare Advantage insurers like Humana slipped while broader indexes also fell.

UnitedHealth Group have had a tumultuous past year, including the fatal shooting of UnitedHealthcare CEO Brian Thompson, right. The suspect in the shooting, Luigi Mangione, appeared at a New York City court last Friday. (Getty)

UnitedHealth Group Inc. stock has been in a rut since early December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A 26-year-old suspect, Luigi Mangione, who led authorities on a five-day manhunt, was in court Friday for the first time since his December arraignment on state murder and terror charges.

Company shares shed more than $100 in value in the weeks following Thompson's death, as the shooting gave rise to an outpouring of grievances about insurance companies.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.